Skip to main content
TipRanks
Go Ultimate75% OFF

Stella Xu Insider Profile

11 Followers

Stella Xu, Director at Design Therapeutics, holds 4.14M shares in Design Therapeutics (Ticker: DSGN), holds 579.71K shares in Tempest Therapeutics (Ticker: TPST), holds 1.10M shares in NextCure (Ticker: NXTC). Most recently, Stella Xu Sold ― shares of Design Therapeutics on Mar 22, 2022 for an estimated value of $11.27M.

Stella Xu's Trading History

DSGN
Design Therapeutics
Mar 22, 2022DirectorInformative Sell11.27M$41.07M
TPST
Tempest Therapeutics
Jun 29, 2021DirectorUninformative Buy―$197.68K
NXTC
NextCure
May 13, 2019DirectorUninformative Buy―$7.37M
ARMO
Armo Biosciences Inc
Jun 22, 2018―Uninformative Sell20.25M$0.00

You May Also Like

Stella Xu insider profile FAQ

What is the percentage of profitable transactions made by Stella Xu?
The percentage of profitable transactions made by Stella Xu is 67%.
What is the average return per transaction made by Stella Xu?
The average return per transaction made by Stella Xu is 32.20%.
What stocks does Stella Xu hold?
Stella Xu holds: DSGN, TPST, ARMO, NXTC stocks.
What was Stella Xu’s latest transaction?
Stella Xu’s latest transaction was an Informative Sell of $11.27M.
What was Stella Xu's most profitable transaction?
Stella Xu’s most profitable transaction was an Informative Buy of NXTC stock on May 13, 2019. The return on the trade was 72.10%.
What is Stella Xu's role in Design Therapeutics?
Stella Xu's role in Design Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.